[8-K] Corebridge Financial, Inc. Reports Material Event
Corebridge Financial disclosed that American International Group, Inc. (the Selling Stockholder) entered into an underwriting agreement with Morgan Stanley & Co. LLC under which the Selling Stockholder agreed to sell 30,000,000 shares of Corebridge common stock at $33.5113 per share. The Underwriter was granted a 30-day option to purchase up to an additional 4,500,000 shares to cover over-allotments. The filing attaches the Underwriting Agreement as Exhibit 1.1 and a legal opinion from Debevoise & Plimpton LLP as Exhibit 5.1, with Debevoise's consent in Exhibit 23.1.
The disclosure describes the transaction terms and supporting exhibits but does not provide details about use of proceeds, the effect on outstanding shares or public float, or any company action beyond furnishing the agreement and opinion.
Corebridge Financial ha comunicato che American International Group, Inc. (l'azionista venditore) ha stipulato un accordo di collocamento con Morgan Stanley & Co. LLC in base al quale l'azionista venditore ha concordato di vendere 30,000,000 azioni ordinarie di Corebridge al prezzo di $33.5113 per azione. Al sottoscrittore 猫 stata concessa un'opzione di 30 giorni per acquistare fino ad ulteriori 4,500,000 azioni per coprire eventuali sovrallocazioni. Il deposito allega l'Underwriting Agreement come Exhibit 1.1 e un parere legale di Debevoise & Plimpton LLP come Exhibit 5.1, con il consenso di Debevoise indicato in Exhibit 23.1.
La comunicazione descrive i termini dell'operazione e gli exhibit a supporto, ma non fornisce dettagli sull'uso dei proventi, sull'effetto sulle azioni in circolazione o sul flottante, n茅 su eventuali azioni societarie oltre alla mera messa a disposizione dell'accordo e del parere legale.
Corebridge Financial divulg贸 que American International Group, Inc. (el accionista vendedor) suscribi贸 un acuerdo de colocaci贸n con Morgan Stanley & Co. LLC, en virtud del cual el accionista vendedor acord贸 vender 30,000,000 acciones ordinarias de Corebridge a $33.5113 por acci贸n. Al suscriptor se le otorg贸 una opci贸n de 30 d铆as para comprar hasta 4,500,000 acciones adicionales para cubrir sobresuscripciones. La presentaci贸n adjunta el Underwriting Agreement como Exhibit 1.1 y una opini贸n legal de Debevoise & Plimpton LLP como Exhibit 5.1, con el consentimiento de Debevoise en el Exhibit 23.1.
La divulgaci贸n describe los t茅rminos de la transacci贸n y los documentos de apoyo, pero no proporciona detalles sobre el uso de los ingresos, el efecto sobre las acciones en circulaci贸n o el flotante, ni acerca de cualquier acci贸n de la compa帽铆a m谩s all谩 de facilitar el acuerdo y la opini贸n legal.
Corebridge Financial鞚� American International Group, Inc.(毵る弰 欤检＜)臧� Morgan Stanley & Co. LLC鞕� 鞚胳垬瓿勳暯鞚� 觳搓舶頄堨溂氅�, 攴胳棎 霐半澕 毵る弰 欤检＜電� Corebridge 氤错喌欤� 30,000,000欤茧ゼ 欤茧嫻 $33.5113鞐� 毵り皝頃橁赴搿� 頃╈潣頄堧嫟瓿� 瓿奠嫓頄堨姷雼堧嫟. 鞚胳垬鞚胳棎瓴岆姅 齑堦臣氚办爼攵勳潉 於╇嫻頃橁赴 鞙勴暣 斓滊寑 於旉皜 4,500,000欤茧ゼ 毵れ垬頃� 靾� 鞛堧姅 30鞚� 鞓奠厴鞚� 攵�鞐悩鞐堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 鞚胳垬瓿勳暯靹�(Exhibit 1.1)鞕� Debevoise & Plimpton LLP鞚� 氩曤鞚橁铂靹�(Exhibit 5.1)臧� 觳秬霅橃柎 鞛堨溂氅�, Debevoise鞚� 霃欖潣電� Exhibit 23.1鞐� 韽暔霅橃柎 鞛堨姷雼堧嫟.
瓿奠嫓電� 瓯半灅 臁瓣贝瓿� 甏�霠� 觳秬氍胳劀毳� 靹る獏頃橁碃 鞛堨溂雮�, 靾橃澋旮� 靷毄觳�, 氚滍枆欤检嫕靾橂倶 鞙犿喌欤检嫕靾橃棎 氙胳箻電� 鞓來枼, 霕愲姅 瓿勳暯 氚� 氩曤鞚橁铂靹� 鞝滉车 鞕胳棎 須岇偓臧� 旆暊 臁办箻鞐� 雽�頃挫劀電� 甑泊鞝侅溂搿� 鞏戈笁頃橃 鞎婌姷雼堧嫟.
Corebridge Financial a annonc茅 qu'American International Group, Inc. (l'actionnaire vendeur) a conclu un contrat de souscription avec Morgan Stanley & Co. LLC en vertu duquel l'actionnaire vendeur a accept茅 de vendre 30,000,000 actions ordinaires de Corebridge au prix de $33.5113 par action. Le souscripteur s'est vu accorder une option de 30 jours pour acheter jusqu'脿 4,500,000 actions suppl茅mentaires afin de couvrir les surallocations. Le d茅p么t joint le contrat de souscription en tant qu'Exhibit 1.1 et un avis juridique de Debevoise & Plimpton LLP en tant qu'Exhibit 5.1, le consentement de Debevoise figurant en Exhibit 23.1.
La communication d茅crit les termes de la transaction et les annexes justificatives, mais ne fournit pas de pr茅cisions sur l'utilisation des produits, l'effet sur les actions en circulation ou le flottant, ni sur d'茅ventuelles mesures de la soci茅t茅 au-del脿 de la simple mise 脿 disposition du contrat et de l'avis juridique.
Corebridge Financial gab bekannt, dass American International Group, Inc. (der ver盲u脽ernde Aktion盲r) einen Zeichnungsvertrag mit Morgan Stanley & Co. LLC abgeschlossen hat, wonach der ver盲u脽ernde Aktion盲r zustimmte, 30,000,000 Stammaktien von Corebridge zu einem Preis von $33.5113 je Aktie zu ver盲u脽ern. Dem Zeichner wurde eine 30-t盲gige Option einger盲umt, bis zu weitere 4,500,000 Aktien zu erwerben, um 脺berzuteilungen abzudecken. Die Einreichung f眉gt den Zeichnungsvertrag als Exhibit 1.1 sowie ein Rechtsgutachten von Debevoise & Plimpton LLP als Exhibit 5.1 bei; die Zustimmung von Debevoise ist in Exhibit 23.1 enthalten.
Die Bekanntgabe erl盲utert die Transaktionsbedingungen und die beigef眉gten Unterlagen, enth盲lt jedoch keine Angaben zur Verwendung des Erl枚ses, zur Auswirkung auf ausstehende Aktien oder den Streubesitz und auch nicht zu sonstigen Ma脽nahmen des Unternehmens 眉ber die Bereitstellung des Vertrags und des Rechtsgutachtens hinaus.
- Underwritten transaction executed with Morgan Stanley & Co. LLC, establishing an orderly sale mechanism.
- Defined pricing at $33.5113 per share for the offered 30,000,000 shares.
- Standard over-allotment option granted for up to 4,500,000 additional shares to cover demand.
- Supporting exhibits filed including the Underwriting Agreement (Exhibit 1.1) and legal opinion (Exhibit 5.1).
- Large block sale of 30,000,000 shares by the Selling Stockholder (AIG) is being offered in the market.
- Filing lacks details on the timing of share distribution and the intended use of proceeds, if any.
- No disclosure in this document of the effect on total outstanding shares or public float post-transaction.
- Limited transaction detail beyond the agreement summary; the description is qualified by the exhibit and may require review of Exhibit 1.1 for complete terms.
Insights
TL;DR: AIG will sell 30 million CRBG shares at a fixed price via an underwritten placement with a 4.5 million over-allotment option.
The filing documents a secondary, underwritten sale where the Selling Stockholder (AIG) sets the offer size and price at $33.5113 per share and Morgan Stanley acts as underwriter. The presence of a standard 30-day over-allotment option suggests the transaction follows market practice to stabilize distribution. The filing includes the underwriting agreement and a legal opinion, but it does not disclose details on how the sale will affect public float, outstanding shares, or timing of distribution; those are material for market impact analysis.
TL;DR: This is a disclosed, underwritten secondary sale by a principal shareholder; governance implications are limited to ownership change disclosure.
The 8-K reports a transparent, underwritten process for a large block sale by the Selling Stockholder, with required exhibits including counsel opinion and consent. From a governance perspective, the filing shows compliance with disclosure norms for a material stock disposition by a major holder. The document does not, however, provide information on post-transaction ownership percentages, any agreements governing the sale beyond the underwriting agreement, or whether the company facilitated registration 鈥� items investors often need to assess ownership and control changes.
Corebridge Financial ha comunicato che American International Group, Inc. (l'azionista venditore) ha stipulato un accordo di collocamento con Morgan Stanley & Co. LLC in base al quale l'azionista venditore ha concordato di vendere 30,000,000 azioni ordinarie di Corebridge al prezzo di $33.5113 per azione. Al sottoscrittore 猫 stata concessa un'opzione di 30 giorni per acquistare fino ad ulteriori 4,500,000 azioni per coprire eventuali sovrallocazioni. Il deposito allega l'Underwriting Agreement come Exhibit 1.1 e un parere legale di Debevoise & Plimpton LLP come Exhibit 5.1, con il consenso di Debevoise indicato in Exhibit 23.1.
La comunicazione descrive i termini dell'operazione e gli exhibit a supporto, ma non fornisce dettagli sull'uso dei proventi, sull'effetto sulle azioni in circolazione o sul flottante, n茅 su eventuali azioni societarie oltre alla mera messa a disposizione dell'accordo e del parere legale.
Corebridge Financial divulg贸 que American International Group, Inc. (el accionista vendedor) suscribi贸 un acuerdo de colocaci贸n con Morgan Stanley & Co. LLC, en virtud del cual el accionista vendedor acord贸 vender 30,000,000 acciones ordinarias de Corebridge a $33.5113 por acci贸n. Al suscriptor se le otorg贸 una opci贸n de 30 d铆as para comprar hasta 4,500,000 acciones adicionales para cubrir sobresuscripciones. La presentaci贸n adjunta el Underwriting Agreement como Exhibit 1.1 y una opini贸n legal de Debevoise & Plimpton LLP como Exhibit 5.1, con el consentimiento de Debevoise en el Exhibit 23.1.
La divulgaci贸n describe los t茅rminos de la transacci贸n y los documentos de apoyo, pero no proporciona detalles sobre el uso de los ingresos, el efecto sobre las acciones en circulaci贸n o el flotante, ni acerca de cualquier acci贸n de la compa帽铆a m谩s all谩 de facilitar el acuerdo y la opini贸n legal.
Corebridge Financial鞚� American International Group, Inc.(毵る弰 欤检＜)臧� Morgan Stanley & Co. LLC鞕� 鞚胳垬瓿勳暯鞚� 觳搓舶頄堨溂氅�, 攴胳棎 霐半澕 毵る弰 欤检＜電� Corebridge 氤错喌欤� 30,000,000欤茧ゼ 欤茧嫻 $33.5113鞐� 毵り皝頃橁赴搿� 頃╈潣頄堧嫟瓿� 瓿奠嫓頄堨姷雼堧嫟. 鞚胳垬鞚胳棎瓴岆姅 齑堦臣氚办爼攵勳潉 於╇嫻頃橁赴 鞙勴暣 斓滊寑 於旉皜 4,500,000欤茧ゼ 毵れ垬頃� 靾� 鞛堧姅 30鞚� 鞓奠厴鞚� 攵�鞐悩鞐堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 鞚胳垬瓿勳暯靹�(Exhibit 1.1)鞕� Debevoise & Plimpton LLP鞚� 氩曤鞚橁铂靹�(Exhibit 5.1)臧� 觳秬霅橃柎 鞛堨溂氅�, Debevoise鞚� 霃欖潣電� Exhibit 23.1鞐� 韽暔霅橃柎 鞛堨姷雼堧嫟.
瓿奠嫓電� 瓯半灅 臁瓣贝瓿� 甏�霠� 觳秬氍胳劀毳� 靹る獏頃橁碃 鞛堨溂雮�, 靾橃澋旮� 靷毄觳�, 氚滍枆欤检嫕靾橂倶 鞙犿喌欤检嫕靾橃棎 氙胳箻電� 鞓來枼, 霕愲姅 瓿勳暯 氚� 氩曤鞚橁铂靹� 鞝滉车 鞕胳棎 須岇偓臧� 旆暊 臁办箻鞐� 雽�頃挫劀電� 甑泊鞝侅溂搿� 鞏戈笁頃橃 鞎婌姷雼堧嫟.
Corebridge Financial a annonc茅 qu'American International Group, Inc. (l'actionnaire vendeur) a conclu un contrat de souscription avec Morgan Stanley & Co. LLC en vertu duquel l'actionnaire vendeur a accept茅 de vendre 30,000,000 actions ordinaires de Corebridge au prix de $33.5113 par action. Le souscripteur s'est vu accorder une option de 30 jours pour acheter jusqu'脿 4,500,000 actions suppl茅mentaires afin de couvrir les surallocations. Le d茅p么t joint le contrat de souscription en tant qu'Exhibit 1.1 et un avis juridique de Debevoise & Plimpton LLP en tant qu'Exhibit 5.1, le consentement de Debevoise figurant en Exhibit 23.1.
La communication d茅crit les termes de la transaction et les annexes justificatives, mais ne fournit pas de pr茅cisions sur l'utilisation des produits, l'effet sur les actions en circulation ou le flottant, ni sur d'茅ventuelles mesures de la soci茅t茅 au-del脿 de la simple mise 脿 disposition du contrat et de l'avis juridique.
Corebridge Financial gab bekannt, dass American International Group, Inc. (der ver盲u脽ernde Aktion盲r) einen Zeichnungsvertrag mit Morgan Stanley & Co. LLC abgeschlossen hat, wonach der ver盲u脽ernde Aktion盲r zustimmte, 30,000,000 Stammaktien von Corebridge zu einem Preis von $33.5113 je Aktie zu ver盲u脽ern. Dem Zeichner wurde eine 30-t盲gige Option einger盲umt, bis zu weitere 4,500,000 Aktien zu erwerben, um 脺berzuteilungen abzudecken. Die Einreichung f眉gt den Zeichnungsvertrag als Exhibit 1.1 sowie ein Rechtsgutachten von Debevoise & Plimpton LLP als Exhibit 5.1 bei; die Zustimmung von Debevoise ist in Exhibit 23.1 enthalten.
Die Bekanntgabe erl盲utert die Transaktionsbedingungen und die beigef眉gten Unterlagen, enth盲lt jedoch keine Angaben zur Verwendung des Erl枚ses, zur Auswirkung auf ausstehende Aktien oder den Streubesitz und auch nicht zu sonstigen Ma脽nahmen des Unternehmens 眉ber die Bereitstellung des Vertrags und des Rechtsgutachtens hinaus.
FAQ
What did Corebridge (CRBG) disclose in this 8-K?
How many Corebridge (CRBG) shares are being sold and at what price?
Who is the selling stockholder and who is the underwriter for the CRBG offering?
Is there an over-allotment (greenshoe) option in the transaction?
Where can I find the full underwriting agreement and legal opinions?
